Endoscopic Reference Score News Today

At week 52 of the Phase 3 EoE KIDS trial, higher exposure dupilumab significantly improved the endoscopic reference score in children with EoE.

Although delayed diagnosis of EoE presents considerable risk to those with this chronic inflammatory disease, novel treatments are providing hope that a new era is on the horizon.

Regardless of a prior history of swallowed topical corticosteroids, dupilumab was proven to be an effective treatment in patients with eosinophilic esophagitis.

Regardless of a prior history of swallowed topical corticosteroids, dupilumab was proven to be an effective treatment in patients with eosinophilic esophagitis.

Regular follow-up can reduce the risk of recurrence, esophageal remodeling, fibrosis, and stricture.

Among the dupilumab treatment and placebo groups, 69% and 71% had previously used STCs, respectively.

With a focus on newly approved treatments and those seemingly on the verge, this years meeting had clear practice-changing implications, says Dr David Johnson.